Artificial sweetener may reduce signs of fatty liver disease
In a new study, researchers found that non-caloric sweeteners can reduce markers of fatty liver disease.
The research was conducted by a team at Children's...
Drug overdose epidemic in the U.S. is transmitted from old to young people
In a new study, researchers found that the generation a person was born into—Silent Generation, Baby Boomer, Generation X or Millennial—strongly predicts how likely...
This home therapy could benefit people with common lung diseases
Chronic obstructive pulmonary disease (COPD) is a chronic lung disease that makes it difficult to breathe.
COPD is the third leading cause of death in the...
Scientists find two new symptoms of COVID-19
In two new studies, researchers report more symptoms of coronavirus. These symptoms include COVID-19 toes and skin rashes.
They found that the coronavirus could cause...
This exercise may effectively prevent frailty in older people
In a new study, researchers found that strength training can be an effective way for older people to stay healthy while at home during...
Some cancer signs can appear many years before diagnosis
A recent study from MIT, Harvard, and elsewhere found early signs of cancer can appear years before diagnosis.
Developing tests for these genetic signs could...
More intense blood pressure control may lower irregular heartbeat risk
Aggressively treating high blood pressure might reduce the risk of a type of irregular heartbeat, according to a new study.
Atrial fibrillation, or AFib, can...
Scientists find early predictor of severe breathing failure in COVID-19
In a new study, researchers found that a very high level of a protein known as suPAR in the blood of patients with COVID-19...
Facemasks risk social isolation for people with hearing difficulties
The use of facemasks to limit the spread of COVID-19 could replace social distancing with social isolation for people with hearing difficulties, a University...
This COVID-19 drug linked to higher risk of irregular heartbeat
Currently, there are no FDA-approved treatments available, the anti-malarial drug, hydroxychloroquine, has emerged as a potential therapy for pneumonia linked to COVID-19.
But in a...